0001567619-20-010906.txt : 20200521 0001567619-20-010906.hdr.sgml : 20200521 20200521163257 ACCESSION NUMBER: 0001567619-20-010906 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200519 FILED AS OF DATE: 20200521 DATE AS OF CHANGE: 20200521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Campbell James H CENTRAL INDEX KEY: 0001757390 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 20902318 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE, SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER, INC. CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 doc1.xml FORM 4 X0306 4 2020-05-19 0 0000722723 HANGER, INC. HNGR 0001757390 Campbell James H 10910 DOMAIN DRIVE, SUITE 300 AUSTIN TX 78758 0 1 0 0 SVP, Chief Clinical Officer Common Stock 2020-05-19 4 A 0 16841 0 A 43446 D Common Stock 2020-05-19 4 F 0 5785 17.12 D 37661 D Stock Options (right to buy) 12.77 2027-05-19 Common Stock 27328 27328 D Shares received pursuant to the Company's Special Equity Plan as a result of the vesting of PSUs awarded in 2017 due to the achievement of predetermined levels of absolute common stock price compounded annual growth period over the three-year performance period. Reflects payment of tax liability by withholding shares of stock incident to vesting of performance shares. Consists of (i) unvested restricted shares totaling 4,556 shares of stock from an initial grant of 4,556 shares of restricted stock that begins to vest on March 9, 2021; (ii) unvested restricted shares and fully vested shares totaling 4,026 shares of stock from an initial grant of 4,405 shares of restricted stock made on March 8, 2019; (iii) unvested restricted shares and fully vested shares totaling 4,771 shares of stock from an initial grant of 5,220 shares of restricted stock made on March 8, 2019; (iv) unvested restricted shares and fully vested shares totaling 5,691 shares of stock from an initial grant of 6,710 shares of restricted stock made on March 9, 2018; (v) unvested restricted shares and fully vested shares totaling 4,220 shares of stock from an initial grant of 7,029 shares of restricted stock made on March 8, 2017; [continued in next footnote] (vi) unvested restricted shares and fully vested shares totaling 1,316 shares of stock from an initial grant of 3,000 shares of restricted stock made on October 11, 2016; and (vii) unvested restricted shares and fully vested shares totaling 2,025 shares of stock from an initial grant of 6,008 shares of restricted stock made on April 29, 2016. Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020. /s/ Jessica Lochmann Allen, Attorney-in-Fact for James H. Campbell 2020-05-21